---
layout: default
title: Generalist versus Specialist Vision Foundation Models for Ocular Disease and Oculomics
---

# Generalist versus Specialist Vision Foundation Models for Ocular Disease and Oculomics

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2509.03421" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2509.03421v1</a>
  <a href="https://arxiv.org/pdf/2509.03421.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2509.03421v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2509.03421v1', 'Generalist versus Specialist Vision Foundation Models for Ocular Disease and Oculomics')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Yukun Zhou, Paul Nderitu, Jocelyn Hui Lin Goh, Justin Engelmann, Siegfried K. Wagner, Anran Ran, Hongyang Jiang, Lie Ju, Ke Zou, Sahana Srinivasan, Hyunmin Kim, Takahiro Ninomiya, Zheyuan Wang, Gabriel Dawei Yang, Eden Ruffell, Dominic Williamson, Rui Santos, Gabor Mark Somfai, Carol Y. Cheung, Tien Yin Wong, Daniel C. Alexander, Yih Chung Tham, Pearse A. Keane

**åˆ†ç±»**: eess.IV, cs.CV

**å‘å¸ƒæ—¥æœŸ**: 2025-09-03

**å¤‡æ³¨**: 39 pages, 8 Figures

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**é¢†åŸŸä¸“ç²¾çš„RETFoundåœ¨çœ¼ç§‘ç–¾ç—…å’Œçœ¼åŸºå› ç»„å­¦ä»»åŠ¡ä¸­ä¼˜äºé€šç”¨è§†è§‰åŸºç¡€æ¨¡å‹**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±äºŒï¼šRLç®—æ³•ä¸æ¶æ„ (RL & Architecture)** **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `è§†ç½‘è†œå›¾åƒåˆ†æ` `çœ¼ç§‘ç–¾ç—…æ£€æµ‹` `é€šç”¨è§†è§‰æ¨¡å‹` `é¢†åŸŸä¸“ç²¾æ¨¡å‹` `è¿ç§»å­¦ä¹ ` `æ•°æ®æ•ˆç‡` `çœ¼åŸºå› ç»„å­¦`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰æ–¹æ³•ä¾èµ–äºé€šç”¨è§†è§‰åŸºç¡€æ¨¡å‹ï¼Œä½†åœ¨çœ¼ç§‘ç‰¹å®šä»»åŠ¡ä¸­è¡¨ç°ä¸è¶³ï¼Œç¼ºä¹é¢†åŸŸé’ˆå¯¹æ€§ã€‚
2. è®ºæ–‡æå‡ºæ¯”è¾ƒé€šç”¨æ¨¡å‹ï¼ˆDINOv2/v3ï¼‰ä¸é¢†åŸŸä¸“ç²¾æ¨¡å‹ï¼ˆRETFoundï¼‰åœ¨è§†ç½‘è†œå›¾åƒåˆ†æä»»åŠ¡ä¸­çš„æ€§èƒ½ã€‚
3. å®éªŒç»“æœè¡¨æ˜ï¼Œå°½ç®¡é€šç”¨æ¨¡å‹å…·æœ‰è‰¯å¥½çš„é€‚åº”æ€§ï¼Œä½†ä¸“ç²¾çš„RETFoundæ¨¡å‹åœ¨çœ¼ç§‘ç–¾ç—…æ£€æµ‹å’Œçœ¼åŸºå› ç»„å­¦ä»»åŠ¡ä¸­è¡¨ç°æ›´ä¼˜ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

åŒ»å­¦åŸºç¡€æ¨¡å‹é€šè¿‡å¤§è§„æ¨¡ä¸´åºŠæ•°æ®é¢„è®­ç»ƒï¼Œåœ¨å„ç§ä¸´åºŠç›¸å…³åº”ç”¨ä¸­è¡¨ç°å‡ºå¼ºå¤§çš„æ€§èƒ½ã€‚RETFoundæ˜¯åœ¨è¿‘ç™¾ä¸‡å¼ è§†ç½‘è†œå›¾åƒä¸Šè®­ç»ƒçš„æ¨¡å‹ï¼Œæ˜¯è¯¥æ–¹æ³•åœ¨è§†ç½‘è†œå›¾åƒåº”ç”¨ä¸­çš„å…¸èŒƒã€‚ç„¶è€Œï¼ŒDINOv2å’ŒDINOv3ç­‰æ—¥ç›Šå¼ºå¤§ä¸”è§„æ¨¡æ›´å¤§çš„é€šç”¨åŸºç¡€æ¨¡å‹çš„å‡ºç°ï¼Œå¼•å‘äº†é¢†åŸŸç‰¹å®šé¢„è®­ç»ƒæ˜¯å¦ä»ç„¶å¿…è¦çš„ç–‘é—®ï¼Œä»¥åŠå¦‚æœå¿…è¦ï¼Œå·®è·åœ¨å“ªé‡Œã€‚ä¸ºäº†ç ”ç©¶è¿™ä¸€ç‚¹ï¼Œæˆ‘ä»¬ç³»ç»Ÿåœ°è¯„ä¼°äº†DINOv2å’ŒDINOv3åœ¨è§†ç½‘è†œå›¾åƒåº”ç”¨ä¸­çš„é€‚åº”æ€§ï¼Œå¹¶å°†å…¶ä¸ä¸¤ä¸ªä¸“ç²¾çš„RETFoundæ¨¡å‹RETFound-MAEå’ŒRETFound-DINOv2è¿›è¡Œäº†æ¯”è¾ƒã€‚æˆ‘ä»¬ä½¿ç”¨å¾®è°ƒå’Œçº¿æ€§æ¢æµ‹ä¸¤ç§é€‚åº”ç­–ç•¥è¯„ä¼°äº†çœ¼ç§‘ç–¾ç—…æ£€æµ‹å’Œå…¨èº«ç–¾ç—…é¢„æµ‹çš„æ€§èƒ½ã€‚è¿›ä¸€æ­¥åˆ†æäº†æ•°æ®æ•ˆç‡å’Œé€‚åº”æ•ˆç‡ï¼Œä»¥è¡¨å¾é¢„æµ‹æ€§èƒ½å’Œè®¡ç®—æˆæœ¬ä¹‹é—´çš„æƒè¡¡ã€‚ç»“æœè¡¨æ˜ï¼Œå°½ç®¡æ‰©å±•é€šç”¨æ¨¡å‹å¯ä»¥åœ¨å„ç§ä»»åŠ¡ä¸­äº§ç”Ÿå¼ºå¤§çš„é€‚åº”æ€§ï¼Œä½†RETFound-DINOv2åœ¨çœ¼ç§‘ç–¾ç—…æ£€æµ‹å’Œçœ¼åŸºå› ç»„å­¦ä»»åŠ¡ä¸­å§‹ç»ˆä¼˜äºè¿™äº›é€šç”¨åŸºç¡€æ¨¡å‹ï¼Œè¡¨ç°å‡ºæ›´å¼ºçš„æ³›åŒ–æ€§å’Œæ•°æ®æ•ˆç‡ã€‚è¿™äº›å‘ç°è¡¨æ˜ï¼Œä¸“ç²¾çš„è§†ç½‘è†œåŸºç¡€æ¨¡å‹ä»ç„¶æ˜¯ä¸´åºŠåº”ç”¨ä¸­æœ€æœ‰æ•ˆçš„é€‰æ‹©ï¼Œè€Œä¸é€šç”¨åŸºç¡€æ¨¡å‹ä¹‹é—´å·®è·çš„ç¼©å°è¡¨æ˜ï¼ŒæŒç»­çš„æ•°æ®å’Œæ¨¡å‹æ‰©å±•å¯ä»¥å¸¦æ¥é¢†åŸŸç›¸å…³çš„æ”¶ç›Šï¼Œå¹¶ä½¿å®ƒä»¬æˆä¸ºæœªæ¥åŒ»å­¦åŸºç¡€æ¨¡å‹çš„å¼ºå¤§åŸºç¡€ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šè®ºæ–‡æ—¨åœ¨è§£å†³é€šç”¨è§†è§‰åŸºç¡€æ¨¡å‹åœ¨çœ¼ç§‘ç–¾ç—…æ£€æµ‹å’Œçœ¼åŸºå› ç»„å­¦ä»»åŠ¡ä¸­è¡¨ç°ä¸å¦‚é¢†åŸŸä¸“ç²¾æ¨¡å‹çš„é—®é¢˜ã€‚ç°æœ‰é€šç”¨æ¨¡å‹è™½ç„¶è§„æ¨¡åºå¤§ï¼Œä½†åœ¨å¤„ç†ç‰¹å®šé¢†åŸŸçš„åŒ»å­¦å›¾åƒæ—¶ï¼Œç”±äºç¼ºä¹é’ˆå¯¹æ€§çš„é¢„è®­ç»ƒï¼Œæ€§èƒ½å—åˆ°é™åˆ¶ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šè®ºæ–‡çš„æ ¸å¿ƒæ€è·¯æ˜¯é€šè¿‡å¯¹æ¯”é€šç”¨è§†è§‰åŸºç¡€æ¨¡å‹ï¼ˆDINOv2, DINOv3ï¼‰å’Œé¢†åŸŸä¸“ç²¾çš„è§†ç½‘è†œå›¾åƒåŸºç¡€æ¨¡å‹ï¼ˆRETFoundï¼‰ï¼Œæ¥è¯„ä¼°é¢†åŸŸç‰¹å®šé¢„è®­ç»ƒçš„å¿…è¦æ€§ä»¥åŠå­˜åœ¨çš„å·®è·ã€‚é€šè¿‡åœ¨ä¸‹æ¸¸ä»»åŠ¡ä¸Šçš„æ€§èƒ½æ¯”è¾ƒï¼Œæ­ç¤ºé¢†åŸŸä¸“ç²¾æ¨¡å‹åœ¨æ•°æ®æ•ˆç‡å’Œæ³›åŒ–èƒ½åŠ›ä¸Šçš„ä¼˜åŠ¿ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šè®ºæ–‡é‡‡ç”¨çš„æ•´ä½“æ¡†æ¶åŒ…æ‹¬ï¼š1) ä½¿ç”¨é€šç”¨è§†è§‰åŸºç¡€æ¨¡å‹ï¼ˆDINOv2, DINOv3ï¼‰å’Œé¢†åŸŸä¸“ç²¾æ¨¡å‹ï¼ˆRETFound-MAE, RETFound-DINOv2ï¼‰ä½œä¸ºç‰¹å¾æå–å™¨ï¼›2) ä½¿ç”¨å¾®è°ƒï¼ˆFine-tuningï¼‰å’Œçº¿æ€§æ¢æµ‹ï¼ˆLinear Probingï¼‰ä¸¤ç§é€‚åº”ç­–ç•¥ï¼Œå°†é¢„è®­ç»ƒæ¨¡å‹åº”ç”¨äºä¸‹æ¸¸çš„çœ¼ç§‘ç–¾ç—…æ£€æµ‹å’Œå…¨èº«ç–¾ç—…é¢„æµ‹ä»»åŠ¡ï¼›3) è¯„ä¼°æ¨¡å‹åœ¨ä¸åŒä»»åŠ¡ä¸Šçš„æ€§èƒ½ï¼Œå¹¶åˆ†ææ•°æ®æ•ˆç‡å’Œé€‚åº”æ•ˆç‡ã€‚

**å…³é”®åˆ›æ–°**ï¼šè®ºæ–‡çš„å…³é”®åˆ›æ–°åœ¨äºç³»ç»Ÿæ€§åœ°æ¯”è¾ƒäº†é€šç”¨è§†è§‰åŸºç¡€æ¨¡å‹å’Œé¢†åŸŸä¸“ç²¾æ¨¡å‹åœ¨çœ¼ç§‘å›¾åƒåˆ†æä»»åŠ¡ä¸­çš„æ€§èƒ½ã€‚é€šè¿‡å®éªŒè¯æ˜ï¼Œå°½ç®¡é€šç”¨æ¨¡å‹å¯ä»¥é€šè¿‡å¤§è§„æ¨¡æ•°æ®è·å¾—è‰¯å¥½çš„æ³›åŒ–èƒ½åŠ›ï¼Œä½†åœ¨ç‰¹å®šé¢†åŸŸï¼Œé¢†åŸŸä¸“ç²¾æ¨¡å‹ä»ç„¶å…·æœ‰ä¼˜åŠ¿ï¼Œå°¤å…¶æ˜¯åœ¨æ•°æ®æ•ˆç‡å’Œæ³›åŒ–èƒ½åŠ›æ–¹é¢ã€‚

**å…³é”®è®¾è®¡**ï¼šè®ºæ–‡çš„å…³é”®è®¾è®¡åŒ…æ‹¬ï¼š1) é€‰æ‹©DINOv2å’ŒDINOv3ä½œä¸ºé€šç”¨è§†è§‰åŸºç¡€æ¨¡å‹ï¼Œå› ä¸ºå®ƒä»¬åœ¨é€šç”¨è§†è§‰ä»»åŠ¡ä¸­è¡¨ç°å‡ºè‰²ï¼›2) é€‰æ‹©RETFoundä½œä¸ºé¢†åŸŸä¸“ç²¾æ¨¡å‹ï¼Œå› ä¸ºå®ƒæ˜¯åœ¨å¤§è§„æ¨¡è§†ç½‘è†œå›¾åƒæ•°æ®é›†ä¸Šé¢„è®­ç»ƒçš„ï¼›3) ä½¿ç”¨å¾®è°ƒå’Œçº¿æ€§æ¢æµ‹ä¸¤ç§é€‚åº”ç­–ç•¥ï¼Œä»¥è¯„ä¼°æ¨¡å‹åœ¨ä¸åŒé€‚åº”ç¨‹åº¦ä¸‹çš„æ€§èƒ½ï¼›4) è¯„ä¼°æ•°æ®æ•ˆç‡å’Œé€‚åº”æ•ˆç‡ï¼Œä»¥é‡åŒ–æ¨¡å‹åœ¨é¢„æµ‹æ€§èƒ½å’Œè®¡ç®—æˆæœ¬ä¹‹é—´çš„æƒè¡¡ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

å®éªŒç»“æœè¡¨æ˜ï¼ŒRETFound-DINOv2åœ¨çœ¼ç§‘ç–¾ç—…æ£€æµ‹å’Œçœ¼åŸºå› ç»„å­¦ä»»åŠ¡ä¸­å§‹ç»ˆä¼˜äºé€šç”¨åŸºç¡€æ¨¡å‹DINOv2å’ŒDINOv3ï¼Œè¡¨ç°å‡ºæ›´å¼ºçš„æ³›åŒ–æ€§å’Œæ•°æ®æ•ˆç‡ã€‚è¿™è¡¨æ˜ï¼Œåœ¨çœ¼ç§‘é¢†åŸŸï¼Œé¢†åŸŸä¸“ç²¾çš„æ¨¡å‹ä»ç„¶å…·æœ‰æ˜¾è‘—ä¼˜åŠ¿ï¼Œå°¤å…¶æ˜¯åœ¨æ•°æ®æœ‰é™çš„æƒ…å†µä¸‹ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶æˆæœå¯åº”ç”¨äºçœ¼ç§‘ç–¾ç—…çš„æ—©æœŸè¯Šæ–­ã€ä¸ªæ€§åŒ–æ²»ç–—æ–¹æ¡ˆçš„åˆ¶å®šä»¥åŠå…¨èº«æ€§ç–¾ç—…çš„é¢„æµ‹ã€‚é€šè¿‡åˆ©ç”¨é¢†åŸŸä¸“ç²¾çš„è§†ç½‘è†œåŸºç¡€æ¨¡å‹ï¼Œå¯ä»¥æé«˜è¯Šæ–­çš„å‡†ç¡®æ€§å’Œæ•ˆç‡ï¼Œä»è€Œæ”¹å–„æ‚£è€…çš„æ²»ç–—æ•ˆæœã€‚æœªæ¥çš„å½±å“åœ¨äºæ¨åŠ¨åŒ»å­¦å½±åƒåˆ†æé¢†åŸŸçš„å‘å±•ï¼Œå¹¶ä¸ºæ„å»ºæ›´æœ‰æ•ˆçš„åŒ»å­¦äººå·¥æ™ºèƒ½ç³»ç»Ÿæä¾›æŒ‡å¯¼ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Medical foundation models, pre-trained with large-scale clinical data, demonstrate strong performance in diverse clinically relevant applications. RETFound, trained on nearly one million retinal images, exemplifies this approach in applications with retinal images. However, the emergence of increasingly powerful and multifold larger generalist foundation models such as DINOv2 and DINOv3 raises the question of whether domain-specific pre-training remains essential, and if so, what gap persists. To investigate this, we systematically evaluated the adaptability of DINOv2 and DINOv3 in retinal image applications, compared to two specialist RETFound models, RETFound-MAE and RETFound-DINOv2. We assessed performance on ocular disease detection and systemic disease prediction using two adaptation strategies: fine-tuning and linear probing. Data efficiency and adaptation efficiency were further analysed to characterise trade-offs between predictive performance and computational cost. Our results show that although scaling generalist models yields strong adaptability across diverse tasks, RETFound-DINOv2 consistently outperforms these generalist foundation models in ocular-disease detection and oculomics tasks, demonstrating stronger generalisability and data efficiency. These findings suggest that specialist retinal foundation models remain the most effective choice for clinical applications, while the narrowing gap with generalist foundation models suggests that continued data and model scaling can deliver domain-relevant gains and position them as strong foundations for future medical foundation models.

